Table 2.
Demographic features of study groups.
| Study Groups (n) | * Age (years) | * BMI (kg /m2) |
|---|---|---|
| Proliferative phase (7) | 43 (32–57) | 27.8 (22–40.5) |
| Secretory phase (9) | 41 (21–47) | 22.6 (18.9–31.6) |
| Postmenopausal (7) | 62 (52–85) | 24.3 (20–39.6) |
| Total Endometrial cancer pts (24) | 67 (37–80) | 30 (23.9–54.4) |
| Endometrioid Grade 1 (6/24) | 61 (46–73) | 37.8 (28.3–46.1) |
| Endometrioid Grade 2 (7/24) | 60 (37–77) | 28.9 (25.8–54.4) |
| Endometrioid Grade 3 (5/24) | 68 (60–80) | 29.8 (23.9–42.7) |
| Malignant Mixed Mullerian Tumor (2/24) | 72.5 (65–80) | 28.6 (24.2–32.9) |
| Clear Cell Carcinoma (2/24) | 71.5 (61–82) | 28.4 (26.6–30.1) |
| Serous Carcinoma (2/24) | 73 (68–78) | 32.7 (NK **-32.7) |
* Data expressed as median (range). ** BMI not known (NK) for 1 patient.